Esophageal Disease Treatment Manufacturer Raises $20.5M

CSA Medical, a Baltimore-based developer of spray devices that treat esophageal disease, has raised $20.5 million in funding, according to a Baltimore Business Journal report.

Advertisement

The company produces a “spray cryotherapy” system that delivers extremely cold liquid nitrogen spray using endoscopy to treat esophageal disease. The funds will be used for post-market clinical studies and ongoing development to support the treatment.

Related Articles on Endoscopy:
Olympus Introduces New Suite of Single-Use Aspiration Needles
EndoChoice Enters Into Agreement With Premier Healthcare Alliance
Barrx Medical Gives $200k to ASGE’s Training Facility

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.